Celanese (CE) Q4 2010 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2010 earnings summary
10 Nov, 2026Executive summary
2010 net sales were $5.918B, up from $5.082B in 2009, as economic recovery lifted volumes and selling prices across most segments.
Operating profit rose to $503M from $290M; net earnings attributable to Celanese Corporation were $377M versus $498M, while continuing-operations earnings were $426M versus $494M.
2011 outlook called for improved results, healthy demand across segments, and earnings growth in every segment, supported by growth, innovation and productivity initiatives.
Financial highlights
Net sales $5.918B vs. $5.082B; gross profit $1.180B vs. $1.003B; operating profit $503M vs. $290M in 2010 and 2009, respectively.
Earnings from continuing operations before tax were $538M vs. $251M; equity earnings from affiliates were $168M vs. $99M.
Net earnings attributable to Celanese Corporation were $377M vs. $498M; continuing-operations EPS was $2.73 basic and $2.69 diluted in 2010.
Other charges, net improved to $46M from $136M; 2010 included a $72M Spondon impairment and $22M accelerated amortization of a supplier-related purchase prepayment.
Outlook and guidance
2011 results were expected to improve from 2010, with healthy demand and earnings growth in every segment, based on a modest global recovery and ongoing initiatives.
Advanced Engineered Materials expected strong seasonal demand and value-in-use pricing; inventory builds would support customer qualification during the Kelsterbach relocation and European expansion.
Consumer Specialties expected relatively flat Q1 demand, slightly lower seasonal sales, continued productivity-led margin expansion and higher Q1 turnaround spending.
Industrial Specialties expected rising 2011 volumes, a robust pricing environment and margin expansion from new products; Acetyl Intermediates expected flat Q1 and overall Asia growth.
2011 cash outflows were forecast at ~$350M for capital expenditures excluding the Kelsterbach relocation and European capacity expansion; Kelsterbach capex was expected at €186M.
Latest events from Celanese
- Sales and operating profit grew, but financing costs and restructuring drove a $253 million loss.CE
Q4 2004 - Pricing and productivity lifted FY 2005 profit, but leverage and input-cost risks persisted.CE
Q4 2005 - Pricing and productivity lifted FY 2006 operating profit 30.3% to $747M.CE
Q4 2006 - Pricing and currency lifted sales 12%, while outages, costs and refinancing weighed on results.CE
Q4 2007 - Recession cut earnings, but cash improved and recovery was expected in 2010.CE
Q4 2009 - FY11 earnings grew on pricing and mix, while major capacity and ethanol investments set up the next growth phase.CE
Q4 2011 - Acetyl pricing and currency dragged FY12 results; 12%–14% earnings growth targeted for FY13.CE
Q4 2012 - A $742 million relocation gain drove record reported profit amid mixed segment trends.CE
Q4 2013 - Sales and adjusted EPS advanced as record cash flow funded growth and shareholder returns.CE
Q4 2014